Broadway Financial (BYFC) CEO receives 23,793-share restricted stock award

Rhea-AI Filing Summary

Argrett Brian E reported acquisition or exercise transactions in this Form 4 filing.

Broadway Financial Corp. reported that President and CEO Brian E. Argrett was granted 23,793 shares of restricted common stock on March 2, 2026 at a reference price of $7.85 per share. Following this equity award, his directly held common stock position increased to 125,752 shares.

The restricted stock will vest over time, with 33% of the shares vesting on the first anniversary of the grant date and the remaining balance vesting ratably over the next 24 months. The filing also notes that the share amounts have been adjusted to reflect a reverse stock split effective October 31, 2023.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Argrett Brian E

Role President/CEO

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	23,793	$7.85	$187K

Holdings After Transaction: Common Stock — 125,752 shares (Direct)

Footnotes (1)

1. Restricted Stock granted March 02, 2026, which shall vest as follows: to the extent of thirty-three percent (33%) of the shares covered thereby on the first anniversary of the date of grant, with the balance vesting ratably over the succeeding twenty-four (24) months. Shares amount adjusted for reverse stock split effective October 31, 2023.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Argrett Brian E

(Last) (First) (Middle)

C/O BROADWAY FINANCIAL CORPORATION

4601 WILSHIRE BLVD., SUITE 150

(Street)

LOS ANGELES CA 90010

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
BROADWAY FINANCIAL CORP \DE\ [ BYFC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President/CEO

3. Date of Earliest Transaction (Month/Day/Year)
03/02/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/02/2026	03/02/2026	A		23,793(1)	A	$7.85	125,752(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Restricted Stock granted March 02, 2026, which shall vest as follows: to the extent of thirty-three percent (33%) of the shares covered thereby on the first anniversary of the date of grant, with the balance vesting ratably over the succeeding twenty-four (24) months.

2. Shares amount adjusted for reverse stock split effective October 31, 2023.

	/s/ Audrey Phillips, Attorney-in-Fact	03/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did BYFC report for Brian E. Argrett?

Broadway Financial reported that CEO Brian E. Argrett received a grant of 23,793 shares of restricted common stock. This equity award was reported as an acquisition under a grant or award transaction code, rather than an open-market purchase or sale.

How many BYFC shares were granted to the CEO and at what price?

The CEO was granted 23,793 shares of Broadway Financial common stock at a reference price of $7.85 per share. This value reflects the reported transaction price per share for the restricted stock award on March 2, 2026.

What is the vesting schedule for the BYFC restricted stock grant?

The restricted stock vests 33% on the first anniversary of the March 2, 2026 grant date. The remaining shares vest ratably over the following 24 months, creating a multi-year incentive structure tied to continued service or performance conditions.

How many BYFC shares does the CEO hold after this transaction?

After the restricted stock grant, CEO Brian E. Argrett directly holds 125,752 shares of Broadway Financial common stock. This total reflects his ownership immediately following the reported acquisition transaction in the Form 4 filing.

Did the BYFC CEO buy or sell shares on the open market in this filing?

The Form 4 describes the transaction as a grant, award, or other acquisition, not an open-market trade. The 23,793 shares were received as restricted stock, rather than being bought or sold through market transactions by the CEO.

How did the BYFC reverse stock split affect the share figures reported?

The filing notes that share amounts are adjusted for a reverse stock split effective October 31, 2023. This means the reported grant and ownership figures already reflect the post-split share count, providing consistency across disclosed holdings.